Release Date: 03/09/09 16:30 Summary: Directors' Interest Notices (4) Price Sensitive: No Download Document 182.92KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%